Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease
Abstract
Key Points
This is the first report to describe dose dependency in the effects of tolvaptan treatment for autosomal dominant polycystic kidney disease. The weight-adjusted average daily dose of tolvaptan was found to be a factor that significantly affected the change in eGFR. If a patient shows tolerance, increasing the tolvaptan dose to the maximum should be...Paper Details
Title
Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease
Published Date
Jul 1, 2021
Journal
Volume
2
Issue
7
Pages
1148 - 1151
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History